Discus thrower Kamalpreet Kaur banned for three years for use of steroid
NEW DELHI: Top Indian discus thrower Kamalpreet Kaur, who achieved stardom for her exploits at the Tokyo Games, was on Wednesday banned for three years for using the prohibited substance Stanozolol, the Athletics Integrity Unit (AIU) has announced.
Her ban will be effective from March 29, 2022.
Kamalpreet was handed a provisional suspension in May this year after testing positive for the steroid, which was found in her sample that AIU collected at Patiala on March 7.
“The AIU has banned Kamalpreet Kaur of India for 3 years for the Presence/Use of a Prohibited Substance (Stanozolol), starting from 29 March 2022. DQ results from 7 March 2022,” the AIU said in a statement.
Kamalpreet had finished sixth at the Tokyo Games in a splendid show.
She made a rapid rise last year when she set a national record of 65.06m in the lead-up to the Tokyo Olympics.
Kamalpreet also finished second in the qualifying round at Tokyo to progress to the final, where she finished sixth with a best throw of 63.70m.
It was the third-best performance by an Indian in a field event at the Games.
Her ban will be effective from March 29, 2022.
Kamalpreet was handed a provisional suspension in May this year after testing positive for the steroid, which was found in her sample that AIU collected at Patiala on March 7.
“The AIU has banned Kamalpreet Kaur of India for 3 years for the Presence/Use of a Prohibited Substance (Stanozolol), starting from 29 March 2022. DQ results from 7 March 2022,” the AIU said in a statement.
Kamalpreet had finished sixth at the Tokyo Games in a splendid show.
She made a rapid rise last year when she set a national record of 65.06m in the lead-up to the Tokyo Olympics.
Kamalpreet also finished second in the qualifying round at Tokyo to progress to the final, where she finished sixth with a best throw of 63.70m.
It was the third-best performance by an Indian in a field event at the Games.
For all the latest Sports News Click Here
For the latest news and updates, follow us on Google News.